Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation

NCT03721874 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Prediabetic State
Substrate Oxidation

Interventions

DRUG: Dapagliflozin 10mg
DRUG: Placebo matching to Dapagliflozin 10 mg

Sponsor

Maastricht University

Collaborators

[object Object]